CTTN and breast cancer: ABL kinase inhibitors significantly reduced invadopodium precursor formation as well as cortactin tyrosine phosphorylation and consequent actin polymerization, extracellular matrix degradation, and three-dimensional (3D) tumor cell invasion in invadopodia of inhibitor-treated breast cancer cells.